(Q38813283)

6 September 2017

title

Cancer and teratogenesis: infrequent occurrence after medical use of immunosuppressive drugs (English)

1 reference

6 September 2017

Cancer and Teratogenesis: Infrequent Occurrence after Medical Use of Immunosuppressive Drugs* (English)

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

12 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

12 February 2023

author name string

G. R. Symington

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A270986

12 February 2023

I. R. Mackay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A270986

12 February 2023

R. P. Lambert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A270986

12 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=270986

12 February 2023

publication date

1 August 1977

1 reference

full work available at URL

6 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1445-5994.1977.tb04397.x

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.1977.tb04397.x/fullpdf

12 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Australian and New Zealand journal of medicine

12 February 2023

published in

1 reference

6 September 2017

volume

7

1 reference

6 September 2017

issue

4

1 reference

6 September 2017

page(s)

368-372

1 reference

Azathioprine in the treatment of systemic lupus erythematosus. A controlled study

6 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Azathioprine in Rheumatoid Arthritis

12 February 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

12 February 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Skin cancer and immunosuppression

12 February 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Immunosuppressive therapy. 2.

12 February 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide

12 February 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Immunosuppressive Drugs and Acute Leukemia

12 February 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Long-term cyclophosphamide therapy in rheumatoid arthritis

12 February 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression

12 February 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Adenocarcinoma of the lung during azathioprine therapy

12 February 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Nephrotic Syndrome Due to Primary Renal Disease in Adults: II. A Controlled Trial of Prednisolone and Azathioprine

12 February 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Acute myelogenous leukemia in two patients treated with azathioprine for nonmalignant diseases.

12 February 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Development of reticulum cell sarcoma during cyclophosphamide therapy

12 February 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Letter: Cyclophosphamide and neoplasia

12 February 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Premalignant and malignant skin tumours in immunosuppressed patients

12 February 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

12 February 2023

Cancer and arthritis

29

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

CONGENITAL ANOMALIES PROBABLY INDUCED BY CYCLOPHOSPHAMIDE

12 February 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Cytotoxic drugs in pregnancy. Review of reported cases

12 February 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Azathioprine (Imuran) and pregnancy

12 February 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Effect of azathioprine on the chromosome complement of human bone marrow cells

12 February 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Chromosome Aberrations in the Child of a Kidney Transplant Recipient

12 February 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

Birth Defects in Child of Male Recipient of Kidney Transplant

12 February 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1977.TB04397.X

12 February 2023

Identifiers

1 reference

6 September 2017

1 reference